SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: TREND1, DewDiligence
Search This Board: 
Last Post: 12/15/2017 10:25:58 AM - Followers: 66 - Board type: Free - Posts Today: 0
SureTrader
Interactive Brokers Advertisement
ENTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA News: Securities Registration: Employee Benefit Plan (s-8) 12/11/2017 04:28:15 PM
ENTA News: Annual Report (10-k) 12/11/2017 04:09:59 PM
ENTA News: Enanta Announces That AbbVie’s MAVIRET™ (glecaprevir/pibrentasvir) Is Now Available in Japan for the Treatment of Chronic... 11/30/2017 07:30:00 AM
ENTA News: Current Report Filing (8-k) 11/20/2017 04:06:57 PM
ENTA News: Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017 11/20/2017 04:01:00 PM
PostSubject
#1556  Sticky Note Transcript of ENTA FY4Q17 CC: DewDiligence 11/21/17 10:40:27 AM
#1545  Sticky Note ENTA 30 MIN DAY WEEK TREND1 11/18/17 03:05:38 PM
#1567   Mavyret scripts—week ending 12/8/17: #msg-136919982. DewDiligence 12/15/17 10:25:57 AM
#1566   New all-time high (eom). DewDiligence 12/13/17 10:37:11 AM
#1565   HEP DART presentations 3 -7 Dec 2017 willyw 12/13/17 10:36:01 AM
#1564   ENTA’s FY2017 10-K has been filed: DewDiligence 12/11/17 05:47:07 PM
#1563   I just added shares at $45.51, FWIW. vinmantoo 11/22/17 12:50:30 PM
#1562   I concur that investors are ascribing no value DewDiligence 11/22/17 11:37:11 AM
#1561   I thought the magnitude of today's selloff was 10nisman 11/21/17 08:15:27 PM
#1560   I thought the magnitude of today's selloff was DewDiligence 11/21/17 05:06:20 PM
#1559   Looks like a good price so far. TREND1 11/21/17 04:51:39 PM
#1557   I only trade at the close. TREND1 11/21/17 10:58:37 AM
#1556   Transcript of ENTA FY4Q17 CC: DewDiligence 11/21/17 10:40:27 AM
#1555   I just added shares at $45.51, FWIW. DewDiligence 11/21/17 10:38:50 AM
#1554   The market seems to dislike the conference call TREND1 11/21/17 10:15:34 AM
#1553   Trend 1 guyschmid 11/21/17 05:51:50 AM
#1552   Enanta expects that its current cash, cash equivalents TREND1 11/20/17 08:01:44 PM
#1551   ENTA FY4Q17 results: DewDiligence 11/20/17 04:04:59 PM
#1550   Mavyret US scripts—week ending 11/10/17: #msg-136327955. DewDiligence 11/20/17 10:59:46 AM
#1549   The big picture is the stock is currently TREND1 11/19/17 01:40:57 PM
#1548   Pretty new to this. Not sure how to CricketPie09 11/19/17 01:36:26 PM
#1547   You must know how to read charts. TREND1 11/19/17 01:34:28 PM
#1546   What does this mean? CricketPie09 11/19/17 01:32:07 PM
#1545   ENTA 30 MIN DAY WEEK TREND1 11/18/17 03:05:38 PM
#1544   Float = 16.02M TREND1 11/14/17 02:19:31 PM
#1543   Earnings Per Share (EPS) = 1.14 TREND1 11/14/17 02:17:11 PM
#1542   Profit/Loss = 21.67M TREND1 11/14/17 02:16:26 PM
#1541   ENTA DAY TREND1 11/14/17 02:14:41 PM
#1540   Mavyret US scripts—week ending 11/3/17: #msg-136101015. DewDiligence 11/10/17 09:42:30 AM
#1539   No news that I'm aware of. DewDiligence 11/07/17 03:10:46 PM
#1538   Yikes! What happened here today? JK2016 11/07/17 03:02:05 PM
#1537   Mavyret US scripts—week ending 10/27/17: #msg-135920382. DewDiligence 11/03/17 10:02:09 AM
#1536   No—still searching for an explanation. DewDiligence 11/02/17 11:33:23 AM
#1535   Dew did you ever come up with an Bickema 11/02/17 11:29:46 AM
#1534   ABBV reduces ENTA equity stake slightly: #msg-135761339. DewDiligence 10/27/17 05:25:47 PM
#1533   Mavyret will have peak annual sales of “multi-billions,” DewDiligence 10/27/17 09:33:14 AM
#1532   Mavyret 3Q17 sales (partial quarter) ~$100M: #msg-135740870. DewDiligence 10/27/17 09:28:25 AM
#1531   The EDP-305 phase-1/1b data are everything investors could DewDiligence 10/23/17 12:47:58 PM
#1530   ENTA reports phase-1/1b data for EDP-305: DewDiligence 10/23/17 11:47:47 AM
#1529   Dew, any thoughts on the data? Or rajaram46 10/23/17 11:40:55 AM
#1528   Caution: My 40% number represents patient share, not DewDiligence 10/20/17 12:17:52 PM
#1527   I saw it in an article recently but Bickema 10/20/17 12:17:22 PM
#1526   Thanks. Where did you find that chart? DewDiligence 10/20/17 12:16:25 PM
#1525   Judging by this Bloomberg chart, 'analyst' aren't expecting Bickema 10/20/17 12:13:36 PM
#1524   AASLD full-text presentations should be available at: DewDiligence 10/20/17 12:12:27 PM
#1523   So is the data accessible? Or will rajaram46 10/20/17 12:06:02 PM
#1522   ENTA’s EDP-305 presentations at AASLD: DewDiligence 10/20/17 11:56:41 AM
#1521   Yes, I think it does. DewDiligence 10/20/17 11:46:06 AM
#1520   Doesn't that imply significant upside to ENTA, on rajaram46 10/20/17 11:44:18 AM
#1519   Mavyret should be able to get a 40% DewDiligence 10/20/17 11:23:21 AM
#1518   Mavyret scripts for week ending 10/13/17: #msg-135560245. DewDiligence 10/20/17 11:21:58 AM
#1517   What's your low estimate guess on where market nowlurking 10/20/17 10:40:58 AM
PostSubject